federal-court

AmEx to cut $1 billion in costs by end of 2017

(Reuters) – Credit card issuer American Express Co said it would cut $1 billion in costs by the end of 2017 as it responds to intensifying competition in the payments industry. AmEx's shares fell 4.1 percent to $60.05 in extended trading on Thursday, after the company reported its fourth straight decline in

More here: 
AmEx to cut $1 billion in costs by end of 2017

federal-court

Boeing to cut 747-8 production in half as demand slows

Boeing Co said on Thursday it will cut production of its 747-8 jumbo jet in half and take a $569 million charge in the fourth quarter as it faces dwindling sales. “The air cargo market recovery that began in late 2013 has stalled in recent months and slowed demand for the 747-8 freighter,” Ray Conner, chief executive of Boeing Commercial Airplanes, said in a statement. Boeing has disclosed in its regulatory filings for months that the costs of making the…

See the original post here:
Boeing to cut 747-8 production in half as demand slows

federal-court

Yahoo to decide next strategic steps after quarterly earnings: sources

Yahoo Inc will decide on its next strategic steps only after releasing quarterly earnings on Feb. 2, people familiar with the matter said, as the company continues to resist investor calls to explore a sale of its core Internet assets. Yahoo wants to gauge shareholder reaction after presenting its strategic vision during the earnings conference call, one of the people said. Yahoo this month rebuffed several potential buyers for its core Internet assets, including private equity firms, the three sources said this week.

Continued here: 
Yahoo to decide next strategic steps after quarterly earnings: sources

federal-court

Drug exec Shkreli, lawmakers clash ahead of congressional hearing

Former pharmaceutical executive Martin Shkreli was on a collision course with Congress on Thursday as lawmakers warned he could be prosecuted for contempt if he does not appear next week for a hearing about drug prices. A lawyer for Shkreli…

Go here to see the original:
Drug exec Shkreli, lawmakers clash ahead of congressional hearing

federal-court

Turing Pharma seeks CEO to replace Shkreli, plans job cuts

Shkreli, 32, resigned as CEO on Friday, a day after his arrest on charges that he had engaged in a Ponzi-like scheme. On Monday, KaloBios Pharmaceuticals said Shkreli was “terminated” as CEO and had resigned from the board. Turing did not specify the number of job cuts in a statement.

Go here to read the rest: 
Turing Pharma seeks CEO to replace Shkreli, plans job cuts

federal-court

KaloBios fires Shkreli as CEO

(Reuters) – Drugmaker KaloBios Pharmaceuticals Inc said it fired Martin Shkreli as chief executive on Dec. 17, the day he was arrested on charges of a securities fraud. Shkreli, who has become the poster child for the issue of soaring prices for prescription medications, has already stepped down as CEO of private drugmaker Turing Pharmaceuticals Inc, in addition to resigning from KaloBios' board of directors. Shkreli was arrested last week for engaging in what U.S. prosecutors said was a Ponzi-like scheme at his former hedge fund MSMB Capital…

See original here: 
KaloBios fires Shkreli as CEO

federal-court

Turing Pharma names chairman to replace Shkreli as CEO

(Reuters) – Martin Shkreli, the poster boy for prescription drug price increases who was arrested for securities fraud this week, has stepped down from his post as chief executive officer of Turing Pharmaceuticals Inc, the company said on Friday. Shkreli was replaced by Turing Chairman Ron Tilles, who said in a statement that the company was committed to continuing to make its flagship drug, Daraprim, which is used to treat…

View original post here:
Turing Pharma names chairman to replace Shkreli as CEO

federal-court

WTO backs agricultural reforms, split on Doha

By Edith Honan NAIROBI (Reuters) – The World Trade Organization reached deals on agricultural export subsidies, food aid and other issues on Saturday, capping a ministerial conference in the Kenyan capital where rich and poor countries had been split over

View post: 
WTO backs agricultural reforms, split on Doha

federal-court

Martin Shkreli says securities fraud charges are ‘baseless’

By Frank McGurty NEW YORK (Reuters) – Martin Shkreli, the pharmaceuticals entrepreneur vilified for jacking up the price of a life-saving AIDS drug, said on Saturday that unrelated securities fraud allegations that resulted in his arrest this week were “baseless and …

See the original post:
Martin Shkreli says securities fraud charges are ‘baseless’

federal-court

Martin Shkreli says securities fraud charges are ‘baseless’

By Frank McGurty NEW YORK (Reuters) – Martin Shkreli, the pharmaceuticals entrepreneur vilified for jacking up the price of a life-saving AIDS drug, said on Saturday that unrelated securities fraud allegations that resulted in his arrest this week were “baseless and without merit.” Federal prosecutors have alleged that Shkreli was running a Ponzi-like scheme at his former hedge fund and a company he headed …

Read the original here: 
Martin Shkreli says securities fraud charges are ‘baseless’

« Previous Page